E84
Conditions
Interventions
Group 1: Measurement (EMG, Vital signs, Isokinetic Biodex, Blood flow, Activity, Qualitiy of life (CFQ 14+R), BIA) also under sinus like whole body vibration
Group 2: Measurement (EMG, Vital signs, I
Sponsors
Medizinische Hochschule Hannover
Eligibility
Sex/Gender
Male
Age
15 Years to 18 Years
Inclusion criteria
Inclusion criteria: CF- Group: assured cystic fibrosis, existing consent form, patients must be able to carry out analyzable pulmonary function tests, a physical performance tests (Biodex) and a set of whole body vibration training stable clinical condition without acute respiratory disease in the last 4 weeks respectively without acute exacerbation of the basic disease no new additionally diagnosted diseases in the last 3 months Control group: existing consent form, patients must be able to carry out analyzable pulmonary function tests, a physical performance tests (Biodex) and a set of whole body vibration training
Exclusion criteria
Exclusion criteria: Cf- Group: patients with problematic microbes (cepacia, MRSA, multiresistant bacteria requiring an isolation) patients coming to an evaluation regarding a lung transplantation patients after lung transplantation patients with an acute respiratory disease in the last 4 weeks respectively with an acute exacerbation of the basic disease patients with an acute health risk resulting in a raised risk for unwanted side effects or influencing the quality of the study results patients with a good adjusted diabetes mellitus can participate Control group: existence of a serious cardiovascular disease, existence of a pulmonary disease, existing of a cardiac pacemaker or a defibrillator, patients with an acute health risk resulting in a raised risk for unwanted side effects or influencing the quality of the study results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. EMG 1.1. median frequenzy 1.2. size of the amplitude 2. M-wave 2.1. lenght of the M-wave 2.2. area of the M-wave 3. exhaustion index, isometric contraction A. Initial examination: 1. Pulmonary function, BMI Z-Score, BIA, HF, RR, AF 2. Quality of life (CFQ., SF36) 3. Activity HAFKA 18 B. Testablauf: 1.EMG, M-Wave and blood flow(Stimulation) Biodex 2.Biodex (max. arbitrary contraction, isometric) EMG, M-Wave and blood flow 3.EMG, M-Wave and blood flow (Stimulation) Biodex 4.Warm up: Biodex, 10´, isokinetic, 5.EMG, M-Wave and blood flow (Stimulation) Biodex 6.Whole body vibration training 90 seconds: EMG, HF, AF 7.EMG, M-Wave and blood flow (Stimulation) Biodex 8.Break 5` 9.Exhasution: Biodex, 50% isometric contraction, 90 seconds 10.Exhaustion: EMG, M-Wave and blood flow direct after 5´ and 10´(Stimulation) Biodex 11.Biodex (max. arbitrary contraction, isometric) EMG, M-Wave and blood flow 12.EMG, M-Wave and blood flow (Stimulation) Biodex | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. vital signs 2. isocinetic Biodex 3. blood flow 4. activity questionnaire HAFKA 18 5. health related quality of life questionnaire SF 36/ CFQ 14+R 6. BIA > all at start of the research projekt | — |
Countries
Germany
Contacts
Public ContactLothar Stein
Institut für Sportmedizin Medizinische Hochschule Hannover
Outcome results
None listed